Astellas Israel is a part of Astellas Established Markets-Commercial (EST-C) region. The Astellas Israeli branch was formed in July 2018, has 26 employees, and is responsible for the sales and marketing of Astellas products in Israel.
We have successfully launched innovative brands and are a respected and strong player in the therapy areas of Oncology and Urology. Astellas Israel is a part of the Pharma-Israel Association. We are determined to answer the unmet medical needs of people in Israel. Building on our heritage in a diverse range of therapeutic areas, we continue to invest in research and development to support new medicines and technologies.
The passion of our people helps us to continue to make a difference to the lives of patients and our values of patient focus, ownership, results, openness, and integrity guide us in everything that we do.
